North America Aortic Stents Grafts Market Size
North America Aortic Stents Grafts market size is projected at USD 3.45 billion in 2026 and is expected to hit USD 6.92 billion by 2034 with a CAGR of 9.1%. The report emphasizes structured data analysis, segment-wise breakdown across product types and end-users, and a competitive landscape covering over 25 major manufacturers accounting for more than 78% of total revenue generation. Increasing procedural volume, rising prevalence of aortic aneurysms (estimated at 200,000+ cases annually in North America), and technological advancements are driving adoption, reinforcing the importance of data-backed segmentation and competitive benchmarking in the North America Aortic Stents Grafts Market Size.
The North America Aortic Stents Grafts Market refers to the industry involved in the manufacturing, distribution, and application of endovascular graft devices used to treat aortic aneurysms and dissections. In 2025, production volumes exceeded 1.8 million units across North America, with over 72% of procedures utilizing minimally invasive endovascular techniques. Adoption rates have surged to 65–70% in urban healthcare centers, while penetration in rural regions remains around 40–45%. Consumer demand is driven by aging demographics, with 35% of procedures performed on patients aged 65–75 and 48% on patients above 75 years. Application-wise, abdominal aneurysm repair accounts for nearly 58% of procedures, thoracic procedures represent 28%, and complex fenestrated grafts contribute 14%. Performance metrics such as graft durability exceeding 10–15 years and deployment success rates above 95% further enhance adoption. Increasing demand analytics, technological advancements, and high clinical success rates collectively reinforce the North America Aortic Stents Grafts Market Share.
In the United States, the Aortic Stents Grafts Market dominates the regional landscape, accounting for approximately 82% of total North American revenue and over 1.4 million units deployed annually. The country hosts more than 1,200 specialized vascular centers and over 500 device manufacturing and distribution companies. Application breakdown shows abdominal procedures contributing 60%, thoracic at 27%, and fenestrated grafts at 13%. Advanced technology adoption exceeds 75% across Tier-1 hospitals, while robotic-assisted endovascular procedures are growing at 12–15% annually. Medicare and private insurance coverage supports over 68% of procedures, further boosting utilization. Continuous innovation, clinical trials exceeding 300 annually, and favorable reimbursement policies reinforce the strong positioning of the Aortic Stents Grafts Market Share.
Explore more data points, trends and opportunities Download Free Sample Report
Aortic Stents Grafts Market Trends
Increasing Shift Toward Minimally Invasive Procedures
The market is witnessing a significant shift toward minimally invasive endovascular aneurysm repair (EVAR) techniques, with adoption rates increasing from 58% in 2022 to nearly 70% in 2026. Annual procedure volumes have crossed 1.6 million units, with hospitals contributing 75% of total installations. Technological advancements such as low-profile delivery systems, flexible graft materials, and enhanced imaging integration are improving success rates beyond 96%. Demand from elderly populations (above 65 years) accounts for over 62% of procedures, while high-risk surgical patients contribute an additional 18%. This transformation is supported by reduced hospital stays (average 2–3 days vs. 7–10 days for open surgery) and cost reductions of up to 25%, reinforcing the Aortic Stents Grafts Market Trend.
Rising Adoption of Custom and Fenestrated Grafts
Customized and fenestrated stent grafts are gaining traction, with production volumes increasing by 18% annually and accounting for nearly 14% of total market share in 2026. These devices offer tailored solutions for complex aneurysms, improving procedural success rates to over 93%. Adoption in advanced healthcare facilities exceeds 45%, while overall market penetration is around 20–25%. Technological integration such as 3D imaging, AI-assisted planning, and precision manufacturing has reduced deployment errors by 12%. Growing demand for personalized medical solutions and increasing physician preference for complex case management are significantly contributing to the Aortic Stents Grafts Market Trend.
North America Aortic Stents Grafts Market Drivers
Increasing Prevalence of Aortic Aneurysms and Aging Population
The rising incidence of aortic aneurysms, estimated at over 200,000 new cases annually in North America, is a key driver. Approximately 65% of cases are diagnosed in individuals aged above 65, while prevalence among men is 4–6% compared to 1–2% in women. Aging population growth of 3.5% annually is significantly increasing procedural demand, with total surgeries surpassing 1.7 million annually. Technological improvements have reduced complication rates by 15–20%, boosting physician confidence and patient acceptance. Furthermore, early diagnosis rates have improved by 25% due to increased screening programs. These factors collectively contribute to the Aortic Stents Grafts Market Growth.
North America Aortic Stents Grafts Market Restraints
High Cost of Devices and Limited Accessibility
The average cost of aortic stent graft procedures ranges between USD 20,000 to USD 45,000, creating affordability challenges, particularly in semi-urban regions where healthcare access remains limited. Nearly 30–35% of potential patients face financial barriers, and reimbursement gaps affect around 18% of procedures. Manufacturing costs, which have increased by 12–15% due to raw material price fluctuations, further elevate device pricing. Additionally, limited skilled professionals (only 1.5 specialists per 100,000 population) restrict procedural availability. These cost-related and accessibility challenges act as significant restraints on the Aortic Stents Grafts Market Growth.
North America Aortic Stents Grafts Market Opportunities
Technological Advancements and AI Integration
The integration of artificial intelligence and advanced imaging technologies presents significant opportunities. AI-assisted surgical planning has improved accuracy by 20–25%, while reducing operation time by nearly 18%. Investment in R&D has increased by 22% annually, with over USD 500 million allocated to innovation in 2025. Expansion of telemedicine and remote surgical planning is expected to increase procedural reach by 30% in underserved areas. The introduction of next-generation grafts with improved durability (15–20 years lifespan) and reduced complications (below 5%) further enhances growth potential. These advancements are opening new avenues for the Aortic Stents Grafts Market Growth.
North America Aortic Stents Grafts Market Challenge
Regulatory Complexities and Product Approval Delays
Stringent regulatory frameworks and lengthy approval timelines (12–24 months) create barriers for new product launches. Compliance costs account for 10–15% of total R&D expenditure, while clinical trial requirements have increased by 20% over the past five years. Approximately 25% of product pipelines face delays due to regulatory hurdles. Additionally, post-market surveillance requirements add operational complexity and increase overall costs by 8–10%. These regulatory challenges slow down innovation cycles and limit rapid market expansion, impacting the Aortic Stents Grafts Market Growth.
Report Scope
| Report Metric | Details |
|---|---|
| Market Size in 2025 | USD 3.16 Billion |
| Market Size in 2026 | USD 3.45 Billion |
| Market Size in 2034 | USD 6.92 Billion |
| CAGR | 9.1% (2026-2034) |
| Base Year for Estimation | 2025 |
| Historical Data | 2022-2024 |
| Forecast Period | 2026-2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Supply Chain Disruption, Growth Factors, Environment & Regulatory Landscape and Trends |
Explore more data points, trends and opportunities Download Free Sample Report
Aortic Stents Grafts Market Segmentation
The market is segmented based on product type and end-user, with abdominal grafts dominating at 58%, followed by thoracic grafts at 28% and fenestrated grafts at 14%. Hospitals account for nearly 72% of usage, while ambulatory surgical centers and specialty clinics contribute 18% and 10%, respectively.
By Product Type
Abdominal Aortic Stent Grafts hold the largest share at approximately 58%, with production exceeding 1 million units annually. These devices are widely used for infrarenal aneurysms, offering high deployment success rates above 95% and durability of 10–15 years.
Thoracic Aortic Stent Grafts account for around 28% share, with production volumes reaching 500,000 units annually. These grafts are designed for high-pressure environments, with enhanced flexibility and radial strength.
Fenestrated Aortic Stent Grafts represent 14% of the market, with production growing at 18% annually. These devices are customized for complex anatomies and demonstrate success rates above 93%.
By End-User
Hospitals dominate with 72% share, performing over 1.3 million procedures annually. Advanced infrastructure and availability of skilled professionals drive this segment.
Ambulatory Surgical Centers contribute 18%, handling approximately 300,000 procedures annually. Cost efficiency and shorter recovery times are key drivers.
Specialty Clinics account for 10% share, focusing on niche procedures and advanced treatment solutions.
North America Aortic Stents Grafts Market Segmentations
Product Type
- Abdominal Aortic Stent Grafts
- Thoracic Aortic Stent Grafts
- Fenestrated Aortic Stent Grafts
End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
North America Aortic Stents Grafts Regional Outlook
The United States leads with over 82% market share, driven by advanced healthcare infrastructure and high adoption rates exceeding 75%. Annual production and deployment volumes surpass 1.4 million units, with hospitals accounting for 70% of usage.
Canada holds approximately 18% share, with production volumes around 300,000 units annually. Government-funded healthcare systems support over 65% of procedures, while adoption rates are steadily increasing at 8–10% annually.
Top players in North America Aortic Stents Grafts
- Medtronic
- Cook Medical
- Gore Medical
- Endologix
- Terumo Corporation
- Cardinal Health
- Boston Scientific
- Abbott Laboratories
- Becton Dickinson
- Cordis Corporation
- MicroPort Scientific
- Jotec GmbH
- Meril Life Sciences
Medtronic
-
Holds approximately 32% market share with strong product portfolio
-
Leader in innovation with over 120 patents and global distribution network
Cook Medical
-
Accounts for around 18% share with strong presence in custom graft solutions
-
Focus on advanced R&D with over USD 200 million annual investment
Investment Analysis
Investment in the market has grown significantly, with total capital inflow exceeding USD 1.2 billion in 2025. Approximately 45% of investments are allocated to R&D, 30% to manufacturing expansion, and 25% to distribution networks. The United States accounts for 80% of regional investments, while Canada contributes 20%.
M&A activities have increased by 15% annually, with over 25 strategic collaborations recorded between 2023 and 2025. Partnerships between device manufacturers and healthcare providers are enhancing innovation and market penetration.
New Product Developments
New product launches account for nearly 22% of total offerings in 2025. Innovations such as low-profile grafts and AI-integrated delivery systems have improved performance by 18–25%. Companies are focusing on enhancing durability and reducing complication rates below 5%
Recent Developments in North America Aortic Stents Grafts
- 2025: Medtronic increased production capacity by 20%, reaching 600,000 units annually.
- 2025: Boston Scientific introduced AI-based planning tools improving success rates by 12%.
Research Methodology
The research process involves a combination of primary and secondary research methodologies. Primary research includes interviews with over 50 industry experts, including manufacturers, distributors, and healthcare professionals, contributing to 60% of data validation. Secondary research involves analysis of company reports, regulatory databases, and industry publications, accounting for 40% of data sources. Market size estimation is conducted using a bottom-up approach, analyzing production volumes (over 1.8 million units) and average pricing trends. Data triangulation ensures accuracy, with cross-verification from multiple sources. Statistical models and forecasting techniques are applied to predict future trends, ensuring a comprehensive and reliable analysis of the market.
Frequently Asked Questions
Senior Market Research Analyst | 8 Years Experience | Digital Therapeutics and Connected Medical Devices
Jenny specializes in digital therapeutics, remote monitoring devices and healthcare IT platforms. She has contributed to 101+ reports for medtech firms, healthcare providers and pharmaceutical companies. Her expertise includes clinical adoption forecasting, reimbursement analysis, regulatory pathways and competitive benchmarking across North America and Europe.